Oral Multiparticulate Dosage Forms – What's new?
International Association for Pharmaceutical Technology
Oral Multiparticulate Dosage Forms – What's new?
Tuesday, 13th November 2012 09:00 to 18:00 h
Opening remarks and scope of the workshop -
Table top exhibition – Manufacturing technologies
Peter KleinebuddeHeinrich-Heine-University Düsseldorf, Germany
Ali R. Rajabi-SiahboomiColorcon Inc., Unites States
Scale up of particle coating in the fluid bed – under-
Staffan FolestadAstraZeneca AB R&D Mölndal, Sweden (not yet confirmed)
Setting the scene - Formulation considerations of
Janssen R&D a division of Janssen Pharmaceutica N.V.,
• layering vs. extrusion/spheronization• mini-matrices
Case study - Micro-particles by supercritical fluids
New Polymers – needs N. N. Bayer Pharma AG, Germany (not yet confirmed)
A guided city tour and a networking dinner will givethe participants the opportunity to get together.
Mini-tabs for MP formulations – challenges, oppor-tunities and trendsJan LüdemannNordmark Arzneimittel GmbH & Co. KG, Germany
CR pellets by melt extrusion – formulation and applicationsBrigitte SkalskyEvonik Industries AG, Pharma Polymers, Germany
Industrial case study – MP formulation from lab toproductionGuido RadtkeBoehringer Ingelheim Pharma GmbH & Co. KG, Germany
Industrial case study – MP tablets: Reminyl controlledrelease multiparticulatesGeert VerreckJanssen R&D a division of Janssen Pharmaceutica N.V., Belgium
Wednesday, 14th November 2012 9:00 to 16:00 h
• Innovative and advanced MP formulations, using
PAT in particle coating Ingela Niklasson-Björn
• Practical aspects of manufacturing and scale up for
AstraZeneca AB R&D Mölndal, Sweden (not yet confirmed)
In-vitro dissolution testing of multiparticulate systems
• Up to date information on QbD and PAT aspects for
Sandra KleinErnst-Moritz-Arndt-University Greifswald, Germany
• Formulation considerations for the treatment of
Taste masking of multiparticulatesJörg Breitkreutz
Heinrich-Heine-University Düsseldorf, Germany
• Table top exhibition on latest innovation in equip-
Case studies IVIVC aspects of MP drug delivery systemsSandra KleinErnst-Moritz-Arndt-University Greifswald, Germany
This will be an excellent opportunity for those new tothe use of multiparticulates as well as those who are
Session 5: Pediactric and geriatric treatment
familiar and experienced in this area. Attendees willbe able to apply their learning from this workshop to
Multiparticulates – the solution for children?
Jörg BreitkreutzUCL School of Pharmacy, United Kingdom
You are kindly invited to submit abstracts for poster
presentations during the conference. Detailed infor-
mation for authors and submission are available onli-ne on the website: www.apv-mainz.de
Deadline for abstract submisssion: 15th October 2012
As an exhibitor you will be also invited to attend thesessions and network at the Get Together Dinner inthe evening that is part of the conference program-me. Price for a table top space with table, chairs andpower supply is 990 EUR plus one mandatory full con-ference registration.
Please contact the APV headquarters Phone +49 6131 9769-85 e-mail [email protected]
By postal service to:APV Arbeitsgemeinschaft fürPharmazeutische Verfahrenstechnik e.V. Kurfürstenstraße 59D-55118 Mainz
Course No. 6469Oral Multiparticulate Dosage Forms – What's new? from 13th to 14th November 2012
IPAP Schizophrenia Algorithm Node Notes This is designed to be used in conjunction with the flowchart version available at www.ipap.org/schiz. 1: Diagnosis of schizophrenia or schizoaffective disorder updated November 02, 2004 It is important to establish diagnosis before considering treatment with psychotropic drugs. For patients who present with psychotic features, the differential usu
JOSHUA REINEKE, Ph.D. Education Doctor of Philosophy in Medical Science at Brown University. Dissertation work was done in the Artificial Organs, Biomaterials and Cellular Technologies Laboratory within the Department of Molecular Pharmacology, Physiology and Biotechnology. Thesis Title: Mechanisms of intestinal microsphere uptake and quantitative analysis of organ distribution for a